• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织多肽抗原在人类前列腺肿瘤中的表达。

Tissue polypeptide antigen expression in human prostate tumors.

作者信息

Ghazizadeh M, Kagawa S, Oguro T, Takigawa H, Sasaki Y, Aihara K

机构信息

Division of Immunohistochemistry, Nippon Medical School, Tokyo, Japan.

出版信息

J Cancer Res Clin Oncol. 1989;115(1):84-8. doi: 10.1007/BF00391605.

DOI:10.1007/BF00391605
PMID:2466035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12211646/
Abstract

Thirty-seven specimens of benign and malignant prostatic tumors were studied for the localization of tissue polypeptide antigen (TPA) by an avidin-biotin-peroxidase complex technique. In addition, 23 metastases of prostatic carcinoma in other organs and 12 nonepithelial tumors of prostate also were studied. All benign and malignant tumors of epithelial origin, including their metastasis, stained positively. Nonepithelial tumors were uniformly negative. In the metastatic lesions, small foci of tumor cells and even single tumor cells could be identified by TPA staining. Immunohistochemical localization of TPA appeared to be a useful tool for assessing the micrometastases of prostatic carcinoma in other organs, especially lymph nodes, or elucidating the epithelial origin of an otherwise undifferentiated prostatic cancer.

摘要

采用抗生物素蛋白-生物素-过氧化物酶复合物技术,对37例前列腺良恶性肿瘤标本进行了组织多肽抗原(TPA)定位研究。此外,还研究了23例前列腺癌在其他器官的转移灶以及12例前列腺非上皮性肿瘤。所有上皮源性良恶性肿瘤,包括其转移灶,均呈阳性染色。非上皮性肿瘤均为阴性。在转移病灶中,TPA染色可识别出小灶肿瘤细胞甚至单个肿瘤细胞。TPA的免疫组化定位似乎是评估前列腺癌在其他器官尤其是淋巴结中的微转移,或阐明未分化前列腺癌上皮起源的有用工具。

相似文献

1
Tissue polypeptide antigen expression in human prostate tumors.组织多肽抗原在人类前列腺肿瘤中的表达。
J Cancer Res Clin Oncol. 1989;115(1):84-8. doi: 10.1007/BF00391605.
2
A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.一项关于恶性脊柱转移瘤的证据的系统回顾:自然病史和识别高风险椎体骨折和脊髓压迫患者的技术。
Health Technol Assess. 2013 Sep;17(42):1-274. doi: 10.3310/hta17420.
3
Study of immortalization and malignant transformation of human embryonic esophageal epithelial cells induced by HPV18 E6E7.人乳头瘤病毒18型E6E7诱导人胚胎食管上皮细胞永生化及恶性转化的研究
J Cancer Res Clin Oncol. 2000 Oct;126(10):589-94. doi: 10.1007/pl00008469.
4
TNM stage, immunohistology, syntactic structure analysis and survival in patients with small cell anaplastic carcinoma of the lung.肺小细胞间变性癌患者的TNM分期、免疫组织学、句法结构分析及生存情况
J Cancer Res Clin Oncol. 1987;113(5):473-80. doi: 10.1007/BF00390042.
5
Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells.5α还原酶抑制剂对雄激素依赖型人前列腺癌细胞的作用。
J Cancer Res Clin Oncol. 2005 Apr;131(4):243-54. doi: 10.1007/s00432-004-0632-1. Epub 2005 Jan 14.
6
Expression of metalloproteinase genes in human prostate cancer.金属蛋白酶基因在人类前列腺癌中的表达
J Cancer Res Clin Oncol. 1991;117(2):144-50. doi: 10.1007/BF01613138.
7
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
8
Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera.通过单克隆抗体CA 19-9和CA 125对正常组织、肿瘤组织及患者血清进行抗原检测。
J Cancer Res Clin Oncol. 1986;111(3):257-65. doi: 10.1007/BF00389242.
9
Immunohistochemical localization of T antigen-like substance in benign hyperplasia and adenocarcinoma of the prostate.T抗原样物质在前列腺良性增生及腺癌中的免疫组化定位
J Urol. 1984 Dec;132(6):1127-30. doi: 10.1016/s0022-5347(17)50060-9.
10
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.晚期前列腺癌治疗中早期与延迟雄激素抑制疗法的比较
Cochrane Database Syst Rev. 2002(1):CD003506. doi: 10.1002/14651858.CD003506.

本文引用的文献

1
Antigenicity of pooled human malignant and normal tissues by cyto-immunological technique; presence of an insoluble, heat-labile tumor antigen.采用细胞免疫学技术检测人恶性组织和正常组织混合样本的抗原性;存在一种不溶性、热不稳定的肿瘤抗原。
Int Arch Allergy Appl Immunol. 1957;10(3):153-84.
2
Biochemical properties of tissue polypeptide antigen.
Biochim Biophys Acta. 1980 Jul 24;624(1):90-101. doi: 10.1016/0005-2795(80)90228-7.
3
Tumor markers in parotid gland carcinomas: immunohistochemical investigations.腮腺癌中的肿瘤标志物:免疫组织化学研究
Cancer Detect Prev. 1983;6(1-2):119-30.
4
Immuno-histochemical localization of tissue polypeptide antigen (TPA) and carcino-embryonic antigen (CEA) in breast cancer. A comparative study.乳腺癌组织中组织多肽抗原(TPA)和癌胚抗原(CEA)的免疫组织化学定位:一项对比研究
Acta Pathol Microbiol Immunol Scand A. 1982 Nov;90(6):471-6. doi: 10.1111/j.1699-0463.1982.tb00124_90a.x.
5
Chemical studies of tissue polypeptide antigen (TPA). III. on the nature of the antigenic determinant(s) of TPA subfraction B1.组织多肽抗原(TPA)的化学研究。III. 关于TPA亚组分B1抗原决定簇的性质
Acta Chem Scand B. 1981;35(5):325-36. doi: 10.3891/acta.chem.scand.35b-0325.
6
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.抗生物素蛋白-生物素-过氧化物酶复合物(ABC)在免疫过氧化物酶技术中的应用:ABC法与未标记抗体(PAP)法的比较。
J Histochem Cytochem. 1981 Apr;29(4):577-80. doi: 10.1177/29.4.6166661.
7
The clinical value of tissue polypeptide antigen in patients with gynecologic tumors.组织多肽抗原在妇科肿瘤患者中的临床价值。
Cancer. 1985 Jun 1;55(11):2618-23. doi: 10.1002/1097-0142(19850601)55:11<2618::aid-cncr2820551114>3.0.co;2-s.
8
The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors.
Am J Clin Pathol. 1987 Sep;88(3):286-96. doi: 10.1093/ajcp/88.3.286.
9
Immunohistochemistry of the cytoskeleton of human prostatic epithelium. Evidence for disturbed organization in neoplasia.人前列腺上皮细胞骨架的免疫组织化学。肿瘤形成中组织结构紊乱的证据。
Am J Pathol. 1987 Feb;126(2):384-95.
10
A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms.对癌症或良性肿瘤患者血清或尿液(或两者)中的组织多肽抗原进行初步评估。
Clin Chem. 1978 Jun;24(6):868-72.